1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 2-2
&NA;,
Preview
|
PDF (760KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
2. |
TDM an aid to combating microbial resistance? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 3-4
Alison Forbes,
Preview
|
PDF (1565KB)
|
|
摘要:
Microbial resistance to currently available drugs as the result of treatment failure is of increasing concern. In addition to emerging resistance to frequently used antibacterial agents, there is now concern about resistance to HIV antiretroviral therapies and antituberculars, as alternative treatments are not always available for these conditions. The usefulness of therapeutic drug monitoring (TDM) in addressing this issue was one of the topics discussed at the 6th International Congress in Therapeutic Drug Monitoring and Clinical Toxicology [Cairns, Australia; September 1999].
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
3. |
Amoebiasisdiagnosis and management |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 4-4
&NA;,
Preview
|
PDF (773KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 5-5
&NA;,
Preview
|
PDF (676KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
5. |
Tamoxifena vital role in breast cancer disease management |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 6-7
Amanda Cameron,
Preview
|
PDF (1579KB)
|
|
摘要:
When choosing which disease management programmes to fund, health maintenance organisations must consider both the needs of its membership and the realities of economic survival - what is good for patients is not necessarily good for the bottom-line. In the case of breast cancer, a programme encouraging the use of the hormonal drug tamoxifen would provide clear benefits for women since the agent has been shown to reduce the risk of breast cancer by 49%. But what about the cost of such a programme? Researchers at the 4th Annual Disease Management Congress [Boston, Massachusetts, US; October 1999] presented data examining the cost of breast cancer in two managed-care populations and the impact of a breast cancer risk management programme.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
6. |
SR271425antitumour agent? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 8-8
&NA;,
Preview
|
PDF (774KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 9-9
&NA;,
Preview
|
PDF (754KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 10-10
&NA;,
Preview
|
PDF (718KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 11-11
&NA;,
Preview
|
PDF (784KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1215,
1999,
Page 12-12
&NA;,
Preview
|
PDF (814KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|